A faster acting mealtime insulin is now approved and available in Canada.
Novo Nordisk Canada Inc. announced that Fiasp (insulin aspart), a…
The immune system mistakenly identifying insulin-secreting beta cells as a potential danger and, in turn, destroying them has long been considered…
New study shows potential to slow the progression of type 1 diabetes
A new research study, which looked at the preservation of beta cell function…
The Centers for Medicare & Medicaid Services (CMS) has announced the determination of a benefit category and coverage for CGM.
In order…
Last week, Lucy Hinchion, aged 20 months, became the youngest child in the world to receive her own cord blood to help prevent or delay the onset of…
The U.S. Food and Drug Administration has expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring (CGM) System to allow…
Starting January 1, people who pay the highest out-of-pocket prices for insulin, such as those who pay full retail price at the pharmacy, may directly…
If you’re feeling down because Diabetes Awareness Month has come to a close, we have something to cheer you up: an amazing set of cookie baking…
The U.S. FDA has approved a new use for Jardiance (empagliflozin), a type 2 diabetes treatment from Boehringer Ingelheim and Eli Lilly and Company…
According to an article published on Seeking Alpha, Novo Nordisk has decided to make some significant changes in its drug development strategy…